Related Experiment Videos
Functional analysis of the lipoglycodepsipeptide antibiotic ramoplanin
Predrag Cudic1, Douglas C Behenna, James K Kranz
1Johnson Research Foundation, Department of Biochemistry and Biophysics, Philadelphia, PA 19104, USA.
Chemistry & Biology
|September 3, 2002
Summary
Ramoplanin effectively combats drug-resistant bacteria like vancomycin-resistant Enterococcus faecium (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) by blocking peptidoglycan synthesis. Structural analysis reveals key features for developing new peptide antibiotics against these pathogens.
Area of Science:
- Microbiology
- Medicinal Chemistry
- Biochemistry
Background:
- Ramoplanin is a peptide antibiotic effective against resistant Gram-positive bacteria.
- Vancomycin-resistant Enterococcus faecium (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) are significant human pathogens.
- Ramoplanin targets bacterial peptidoglycan (PG) biosynthesis.
Purpose of the Study:
- To elucidate the mechanism of ramoplanin's inhibition of PG biosynthesis.
- To identify key structural features of ramoplanin essential for its antibiotic activity.
- To explore the potential for developing novel ramoplanin-derived antibiotics.
Main Methods:
- Semisynthetic modification of ramoplanin.
- Nuclear Magnetic Resonance (NMR) analyses.
- Biochemical assays to assess PG biosynthesis inhibition.
Main Results:
- Ramoplanin binds to Lipid intermediates I and II, distinct from vancomycin's target.
- This binding prevents substrate utilization by essential PG biosynthesis enzymes.
- Key structural determinants for ramoplanin's activity and PG recognition were identified.
Conclusions:
- Ramoplanin's mechanism involves occlusion of PG precursors.
- A minimalist ramoplanin pharmacophore has been defined.
- This research paves the way for designing new peptide or peptidomimetic antibiotics against VRE, MRSA, and similar pathogens.